Sign inJoin waitlistJoin the waitlist

Dimitrios Kontoyiannis

Deputy Head, Internal Medicine-Lead · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

Internal Medicine-lead Division · University of Texas M D Anderson Cancer Center
Present
Division of Internal Medicine · University of Washington School of Medicine
Present
University of Texas M D Anderson Cancer Center
Present

Vanderbilt Center for Patient and Professional Advocacy
2020
Infectious Disease
Massachusetts General Hospital
1994–1998
Whitehead Institute for Biomedical Research/MIT
1997–1998
Massachusetts Institute of Technology Medical Department
1995–1996
Internal Medicine
Baylor College of Medicine
1991–1994
University of Texas M D Anderson Cancer Center
1989–1991
401 General Army Hospital
1988–1989
1987-1988 Second Lieutenant of the Medical Corp
1987–1988
Doctor of Medicine
1983–1987

Research

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group…
Clinical Infectious Diseases · 2020 · 2,370 citations
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases · 2016 · 2,172 citations
Epidemiology and outcome of zygomycosis: a review of 929 reported cases
Review · Clinical Infectious Diseases · 2005 · 2,104 citations

Issam Raad
88 papers
Thomas Walsh
70 papers
JT
Jeffrey Tarrand
54 papers
GB
Gerald Bodey
34 papers
Harrys Torres
34 papers · 11 as a fellow
Michail Lionakis
33 papers
KR
Kenneth Rolston
30 papers
Roy Chemaly
30 papers · 2 as a resident
Hagop Kantarjian
26 papers
Richard Champlin
23 papers
Peter Pappas
21 papers
KM
Kieren Marr
20 papers

Grants

Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk Stratification, Diagnosis and Management of the Disease
National Institute of Allergy and Infectious Diseases · P01
Project lead · $1.2M · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
2025–2030
Immuno-Protection and Adjunctive Therapeutic Efficacy of Nebulized Pattern Recognition Receptor Agonists in Immunosuppressed Mice with Mold Pneumonia
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $205K · University of Tx Md Anderson Can Ctr
2026–2028
Development of an Acute Myeloid Leukemia Murine Model of Invasive Pulmonary Aspergillosis to Gain Insights into the Role of Leukemia and Its Treatments in the Pathobiology of Aspergillosis
National Institute of Allergy and Infectious Diseases · R03
Contact PI · $162K · University of Tx Md Anderson Can Ctr
2022–2025
Redirected T Cell Therapy to Cure Invasive Fungal Infections
National Institute of Allergy and Infectious Diseases · R33
Contact PI · $1.4M · University of Tx Md Anderson Can Ctr
2016–2022

Clinical trials

Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2025–2032